CureAge Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $665K

  • Investors
  • 5

CureAge Therapeutics General Information

Description

Developer of genetic therapies designed to treat peripheral nerve disorders. The company specializes in ribonucleic acid systems with a focus on neurofibromatosis and gene therapy platforms tailored for rare neurological conditions, enabling patients with inherited nerve disorders to access targeted and potentially transformative treatments.

Contact Information

Formerly Known As
Hermogen Bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 16 Stapleton Court, Packington Road
  • London W3 8FB
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 16 Stapleton Court, Packington Road
  • London W3 8FB
  • England, United Kingdom

CureAge Therapeutics Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CureAge Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 16-Jul-2026 $665K Completed Generating Revenue
2. Accelerator/Incubator 11-Dec-2025 Completed Generating Revenue
1. Seed Round 08-Oct-2025 Completed Startup
To view CureAge Therapeutics’s complete valuation and funding history, request access »

CureAge Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordianry
To view CureAge Therapeutics’s complete cap table history, request access »

CureAge Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CureAge Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Government
Charles River Incubator Program Accelerator/Incubator
Children's Tumor Foundation Corporation Minority
Deep Science Ventures Venture Capital Minority
Nothing is Forever Other Minority
To view CureAge Therapeutics’s complete investors history, request access »

CureAge Therapeutics FAQs

  • When was CureAge Therapeutics founded?

    CureAge Therapeutics was founded in 2024.

  • Where is CureAge Therapeutics headquartered?

    CureAge Therapeutics is headquartered in London, United Kingdom.

  • What is the size of CureAge Therapeutics?

    CureAge Therapeutics has 5 total employees.

  • What industry is CureAge Therapeutics in?

    CureAge Therapeutics’s primary industry is Biotechnology.

  • Is CureAge Therapeutics a private or public company?

    CureAge Therapeutics is a Private company.

  • What is CureAge Therapeutics’s current revenue?

    The current revenue for CureAge Therapeutics is .

  • Who are CureAge Therapeutics’s investors?

    Innovate UK, Charles River Incubator Program, Children's Tumor Foundation, Deep Science Ventures, and Nothing is Forever have invested in CureAge Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process